Mohammad Said Ramadan
Overview
Explore the profile of Mohammad Said Ramadan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramadan M, Gallo R, Patauner F, Bertolino L, Durante-Mangoni E
Rev Cardiovasc Med
. 2024 Jul;
23(8):277.
PMID: 39076625
Novel cardiac devices, including the MitraClip system, occluder devices, leadless pacemakers, and subcutaneous implantable cardioverter defibrillators (S-ICD), are mostly used in the management of patients who are at high risk...
2.
Ramadan M, Bertolino L, Boccia F, Hamieh M, Peluso A, Gallo R, et al.
Intern Emerg Med
. 2023 Dec;
19(2):455-464.
PMID: 38129537
The objective of the study was to assess the short- and long-term mortality of infective endocarditis (IE) among people who inject drugs (PWID). Using prospectively collected data on hospitalized patients...
3.
Bertolino L, Ramadan M, Zampino R, Durante-Mangoni E
Infection
. 2023 Jun;
51(5):1241-1248.
PMID: 37386329
Purpose: Progress of interventional cardiology has boosted the use of newer cardiac devices. These devices are perceived to be less prone to infections compared to traditional surgical prostheses, but little...
4.
Ramadan M, Boccia F, Moretto S, De Gregorio F, Gagliardi M, Iossa D, et al.
J Clin Med
. 2022 Oct;
11(19).
PMID: 36233646
Background: Chronic hepatitis C (CHC) is associated with hepatic and extrahepatic complications, including cardiovascular disease (CVD). The effects of sustained virological response (SVR) and liver fibrosis on CVD risk are...
5.
Ramadan M, Gallo R, Lugara M, Gambardella M, Oliva G, Bertolino L, et al.
J Chemother
. 2021 Dec;
34(6):360-366.
PMID: 34923922
Dalbavancin is a novel lipoglycopeptide antibiotic, characterized by a broad spectrum of activity against Gram-positive cocci. However, its efficacy in spondylodiscitis treatment is not fully established. All adult patients diagnosed...
6.
Ramadan M, Bertolino L, Zampino R, Durante-Mangoni E
Clin Microbiol Infect
. 2021 Jun;
27(9):1250-1261.
PMID: 34171458
Background: Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease. Objectives: To assess the range of cardiac sequelae...
7.
Ramadan M, Bertolino L, Marrazzo T, Florio M, Durante-Mangoni E
Intern Emerg Med
. 2021 May;
16(8):2051-2061.
PMID: 34046852
Growing reports since the beginning of the pandemic and till date describe increased rates of cardiac complications (CC) in the active phase of coronavirus disease 2019 (COVID-19). CC commonly observed...
8.
Ramadan M, Russo V, Nigro G, Durante-Mangoni E, Zampino R
J Clin Med
. 2021 Apr;
10(8).
PMID: 33917867
The liver-heart axis is a growing field of interest owing to rising evidence of complex bidirectional interplay between the two organs. Recent data suggest non-alcoholic fatty liver disease (NAFLD) has...